Weakley Ronald G MD is categorized under Electrolysis and Epilatory Services in Modesto, CA and active since 2002.
Weakley Ronald G MD was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Electrolysis and Epilatory Services business, which does work in the B2C market, and is classified as a Electrolysis and Epilatory Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ronald Weakley at the company’s single location by writing to 1401 Spanos Court # 124, Modesto, California CA 95355 or by phoning (209) 525-3883. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Weakley Ronald G MD |
| Contact Person: | Ronald Weakley |
| Address: | 1401 Spanos Court # 124, Modesto, California 95355 |
| Phone Number: | (209) 525-3883 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Electrolysis and Epilatory Services |
| SIC Code: | 7231 |
| NAICS Code: | 6211110 |
| Share This Business: |
Weakley Ronald G MD was started in 2002 to provide professional Electrolysis and Epilatory Services under the SIC code 7231 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ronald Weakley for inquiries that concern Weakley Ronald G MD by calling the company number (209) 525-3883, as your correspondence is most welcome. Additionally, the physical location of the single location of Weakley Ronald G MD can be found at the coordinates 37.6698,-120.9723 as well as the street address 1401 Spanos Court # 124 in Modesto, California 95355.
For its online presence, you may visit Weakley Ronald G MD’s website at and engage with its social media outlets through on Twitter and on Facebook.